Cerebral palsy doesn't cause death in adults, so why is it still listed as an underlying cause?

Listing cerebral palsy as the main cause of death for adults with the disease can contribute to a lack of understanding about how the condition interacts with various secondary illnesses and complications.

9:11 AM

Author | Valerie Goodwin

two people one with wheelchair one with walking canes orange background see back of them
Cerebral palsy should never be listed as a cause of death. Jacob Dwyer, Michigan Medicine

Adults living with cerebral palsy cannot die from cerebral palsy, yet the condition is commonly listed as an underlying cause of death on records for adults with cerebral palsy. Research from the University of Michigan Health System suggests that mislabeling the cause of death for patients with cerebral palsy can set back appropriate care for individuals with cerebral palsy.

When there is no primary cause and no autopsy performed, cerebral palsy is commonly written as the underlying cause of death. Known as diagnostic overshadowing, the incorrect listing not only does a disservice to the population of individuals living with the condition, but it continues a false narrative that patients can die from the condition alone.

"For someone who is trying to help patients with cerebral palsy live long and healthy lives, listing their death as cerebral palsy is a problem because it doesn't uncover the actual cause of mortality," said Mark Peterson, Ph.D., M.S., FACSM, associate professor of physical medicine and rehabilitation at Michigan Medicine. "It actually reduces our understanding of the natural history of the condition."

In the research study "Underlying Causes of Death among Adults with Cerebral Palsy" published in the Journal of Clinical Medicine, Peterson and colleagues found that over 25,000 adult deaths in the United States between 1999 and 2019 had listed cerebral palsy as the underlying cause of death. Many of them listed respiratory illness as the secondary cause.

Respiratory illness is a common cause of death for patients with cerebral palsy since they are prone to pneumonia, respiratory failure, and aspiration. Other common causes can include cardiovascular issues and organ failures.

Ideally, the primary cause of death listed would be the illness or condition the individual had when they died if such information is available. Then, cerebral palsy would be listed as a secondary cause or noted in the record. This method would give researchers and health care providers a better base to start understanding how different conditions and illnesses interact with cerebral palsy across a patient's lifespan.

Like Podcasts? Add the Michigan Medicine News Break on Spotify, Apple Podcasts or anywhere you listen to podcasts.

This information can then be used in a preventative capacity or to treat patients living with cerebral palsy that may experience these illnesses and conditions in the future. Not properly listing the cause of death leads to a lack of understanding about the condition since it is unknown what the individual truly died of.

"A correct cause would inform public health and clinical coordination of care. This information could give insight to providers and create a better understanding of how to address these underlying causes in patients with cerebral palsy," Peterson said.

Cerebral palsy has historically been viewed as a pediatric condition since it arises in infancy. This means that most patients with cerebral palsy are limited to their pediatric care team and can struggle to receive appropriate care as an adult. Today, there are more adults in the United States living with cerebral palsy than children.

Peterson recommends that patients with cerebral palsy find primary care providers that can treat more than just symptoms of cerebral palsy.

"Many patients with cerebral palsy are more susceptible to preventable chronic conditions." Peterson said. "It is important to have a primary care provider that can understand your cerebral palsy and any other conditions that may arise with it."

Peterson stated that he hopes this research becomes an educational tool for those who study and care for patients with cerebral palsy, as well as clinicians and medical examiners that are responsible for listing underlying causes of death.

"The more education there is about how different conditions interact with cerebral palsy, the more work that can be done to prevent or address these conditions in patients."

The University of Michigan Health System currently houses a clinic to help adults with cerebral palsy transition from pediatric care into and throughout proper adult care. Clinic providers Edward Hurvitz, MD and Heidi Haapala, MD work to provide proper care and referrals for patients with cerebral palsy, including mental health referrals.

Live your healthiest life: Get tips from top experts weekly. Subscribe to the Michigan Health blog newsletter

Headlines from the frontlines: The power of scientific discovery harnessed and delivered to your inbox every week. Subscribe to the Michigan Health Lab blog newsletter

Additional authors include Allecia M. Wilson, M.D., Department of Pathology, Michigan Medicine, University of Michigan, Edward A. Hurvitz, M.D., Department of Physical Medicine and Rehabilitation, Michigan Medicine, University of Michigan.

Paper cited: "Underlying Causes of Death among Adults with Cerebral Palsy" Journal of Clinical Medicine. DOI: 10.3390/jcm11216333 


More Articles About:

Rounds Wellness and Prevention All Research Topics Education Future Think Cerebral Palsy
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Blue round cells in three pictures showing how they change under stress.
Health Lab

Timing is of the essence for RNA during stress

Key determiners of which RNA can be read to make proteins is time. Previous thinking was that a cell under threat would quickly make these RNAs in the nucleus and immediately push them into the cytoplasm.
Blue and yellow illustration of DNA helix
Health Lab

New anti-cancer strategy shows promise in preclinical studies

New cancer therapeutic strategy rewires protein interactions to improve efficacy and reduce potential side effects.
Closeup of newborn baby, whose head is held by a blue medical gloved hand. Blue gloved hand also holds a stethoscope to baby's chest.
Health Lab

More babies with hypoplastic left heart syndrome surviving critical period between surgeries

Collaborative effort helped sustain improvements in survival for babies born with hypoplastic left heart syndrome (HLHS), a serious congenital heart condition that requires multiple surgeries.
Rachel Upjohn Building groundbreaking ceremony
News Release

How U-M helped bring depression out of the darkness

The history of the founding of the Eisenberg Family Depression Center at the University of Michigan, the nation's first center focused on research, community outreach and stigma reduction in depression and bipolar disorder.
UMich Med Mosaic on blue background with colorful geometric shapes
UMich Med Mosaic

Beyond the White Coat: Disability, Neurodiversity and Advocacy in Medical School

In this episode of UMich Med Mosaic, host Mackenzie Kay sits down with medical students Jill Maudlin, Sarah Renberg and Bella Johnson to discuss their experiences as disabled and neurodivergent trainees at the University of Michigan Medical School. They reflect on the personal journeys that led them to medicine, the challenges and strengths that accompany living with disabilities and chronic health conditions and the importance of representation within the medical profession. The conversation explores how disability shapes their approaches to patient care, advocacy and teamwork, as well as the role of the Medical Students for Disability Health Advocacy (MSDHA) organization in creating community and advancing accessibility initiatives. They also discuss Michigan’s accommodations in medical education, efforts to improve disability-related curriculum content and the importance of building a culture where disabled and neurodivergent students can thrive.
Minding Memory with a microphone and a shadow of a microphone on a blue background
Minding Memory

Antipsychotic Use in Nursing Homes: Balancing Medication Safety, Policy, and Dementia Care

In this episode, Lauren Gerlach and Matt Davis speak with Theresa Shireman, PhD, Director of the Center for Gerontology and Healthcare Research and a Professor of Health Services, Policy and Practice and Epidemiology at the Brown University School of Public Health. Dr. Shireman’s research focuses on pharmaceutical policy, pharmacoepidemiology, health services research, and medication use among vulnerable populations. Dr. Shireman discusses her recent study, "Impact of Federal Antipsychotic Use Policy in Nursing Homes on New Diagnoses for Approved Indications in Dementia Residents," published in the Journal of the American Geriatrics Society. The study examines whether federal policies designed to reduce antipsychotic use in nursing homes were associated with increases in new diagnoses of conditions, such as schizophrenia, that exclude residents from publicly report antipsychotic quality measures. Using an interrupted time-series design, the researchers examined changes following the 2012 National Partnership to Improve Dementia Care and the 2015 addition of antipsychotic use to the Nursing home Five-Star Quality Rating System. They found that neither policy was associated with an increase in new exclusionary diagnossees, challenging concerns that nursing homes were increasingly assigning these diagnoses to circumvent restrictions on antipsychotic use. The conversation also explores the benefits and risks of antipsychotic medications for people living with dementia, including the potential for serious adverse effects such as sedation, falls, stroke, and increased mortality. Dr. Shireman discusses how public reporting and financial incentives can influence prescribing practices,the limitations of using a single quality measure to evaluate nursing home care, and the importance of balancing medication safety and residents’ individual needs. The discussion highlights the need for shared decision-making among clinicians, nursing home staff, residents, and families, as well as greater investment in staffing, resources, and nonpharmacological approaches to improve quality of life for people living with dementia. The transcript for this episode can be found here.